CClinicalTrials.gg
CompletedNCT01832376Updated Oct 31, 2018

Treatment of Calcific Tendinitis by Ultrasound-guided Needle Lavage

An interventional study of Ultrasound guided needle lavage in Calcific Tendinitis, sponsored by Martina Hansen's Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-31.

Sponsored by Martina Hansen's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Study population: Subjects with long standing symptoms from calcific tendonitis, non-responsive to other forms of conservative treatment

Study method: A cohort of 50 patients with symptomatic calcific tendonitis will be treated by ultrasound-guided needle lavage. At baseline all study subjects will be assessed by clinical examination, imaging of the shoulder by x-ray and sonography and by the self-report section of the American Shoulder and Elbow Surgeons score (ASES). Follow-up will be performed after 1 and 4 weeks (score only), 3 (clinical, score, ultrasound, x-ray), 6 and 12 months (score only), and after 24 months (clinical, score, ultrasound, x-ray). Patients with insufficient treatment effect will be offered physiotherapy, re-lavage or surgical treatment by acromioplasty.

Purpose of the study: The investigators want to find out

  • if shoulder function, measured by a shoulder score, will increase during follow-up
  • how much of the calcific material can be aspirated (in ml)
  • to which extend the calcific deposit disappears on x-rays and sonographic images
  • how many patients will need surgical treatment
02

Conditions studied

  • Calcific Tendinitis

Browse trials for

Keywords

  • Calcific tendinitis
  • Shoulder
  • Needle lavage
  • Ultrasound-guided
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

This study's enrollment of 52 is close to the median of 50 across 339 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Martina Hansen's Hospital is the lead sponsor of 12 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Shoulder pain for at least 6 months, localised laterally on the upper humerus
  • Painful arc
  • Positive Hawkins test and/or Neers tegn for impingement
  • Calcific deposit of >= 5 mm on shoulder x-ray, verified on sonography with a localisation in the supraspinatus or infraspinatus tendon

Exclusion criteria

Exclusion Criteria:

  • The presence of other local or systemic diseases affecting shoulder function like arthritis, inflammatory arthropathy or instability
  • Symptoms from a cervical root syndrome
  • Sonographic or MRI findings for a rotator cuff tear
  • Earlier surgery in the study shoulder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    Ultrasound guided needle lavage

    Ultrasound guided needle lavage

    Procedure: Ultrasound guided needle lavage

Interventions

  • ProcedureUltrasound guided needle lavage

    A 18-gauge needle connected to a 5 ml syringe with 4 ml of saline solution will be used to puncture the calcification with freehand technique and under constant sonographic monitoring. With the tip of the needle placed in the center of the deposit, the calcification will be flushed. If backflow of calcific material can be identified in the syringe, lavage of the deposit will be performed by successive propulsion and aspiration with the syringe plunger. In cases where no material can be extracted, repeated perforation of the deposit will be performed to possibly initiate or accelerate spontaneous resorption.

    Also known as: Barbotage

06

What researchers measure

Primary outcomes

  1. The self-report section of the American Shoulder and Elbow Surgeons score (ASES)

    The self-report section of the American Shoulder and Elbow Surgeons score (ASES) consists of two equally weighted parts for pain and shoulder function, each contributing 50 points to a maximum score of 100. Pain measurement is performed on a 10 cm visual analogue scale divided into 1 cm increments. Shoulder function is measured by classifying 10 activities of daily living on a four-point ordinal scale. Change in points on the ASES scale from baseline to 24 month follow-up is the primary outcome measure of our study.

    Time frame: Baseline and 24 months

Secondary outcomes

  1. Number of patients who need operative treatment during follow-up

    Time frame: Baseline to 24 months

Other outcomes

  1. Size of the calcific deposit as determined on X-rays of the affected shoulder

    Standardized X-rays of the shoulder are taken at baseline, 3 and 24 month follow-up and the size of the calcific deposits will be measured and compared between examinations

    Time frame: Baseline to 3 months and 24 months

07

Study locations

1 site
  • Martina Hansens Hospital
    Sandvika, 1306, Norway
08

References and documents

Publications

  • Moosmayer S and Aasen IB. Ultrasound- Guided Percutaneous Needle Treatment and Steroid Injection for Calcific Tendinopathy of the Shoulder: Can the Orthopedic Surgeon do it?. M J Orth. 3(1): 020, 2018.
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01832376
Lead sponsor
Martina Hansen's Hospital
Responsible party
Stefan Moosmayer (MD, PhD, Martina Hansen's Hospital) — Principal investigator
First posted
Apr 16, 2013
Start date
Jun 2011
Primary completion
Feb 2016
Completion
May 2018
Last update
Oct 31, 2018

Study contacts

Stefan Moosmayer, MD, PhD
principal investigator · Martina Hansens Hospital, Sandvika, Norway

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion